Isabel Tritschler

3.3k total citations · 1 hit paper
15 papers, 2.6k citations indexed

About

Isabel Tritschler is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Isabel Tritschler has authored 15 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology and Allergy. Recurrent topics in Isabel Tritschler's work include Cell Adhesion Molecules Research (5 papers), TGF-β signaling in diseases (5 papers) and Glioma Diagnosis and Treatment (4 papers). Isabel Tritschler is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), TGF-β signaling in diseases (5 papers) and Glioma Diagnosis and Treatment (4 papers). Isabel Tritschler collaborates with scholars based in Switzerland, Germany and United States. Isabel Tritschler's co-authors include Michael Weller, Wolfgang Wick, Christiane A. Opitz, Ulrike Litzenburger, Michael Platten, Christian Lutz, Martina Ott, Dieter Schrenk, Irina Lehmann and Felix Sahm and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Isabel Tritschler

15 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

2011 1.4k citations Christiane A. Opitz, Ulrike Litzenburger et al. Nature profile →

Peers

Countries citing papers authored by Isabel Tritschler

Since Specialization

Citations

This map shows the geographic impact of Isabel Tritschler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Tritschler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Tritschler more than expected).

Fields of papers citing papers by Isabel Tritschler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Tritschler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Tritschler. The network helps show where Isabel Tritschler may publish in the future.

Co-authorship network of co-authors of Isabel Tritschler

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Tritschler. A scholar is included among the top collaborators of Isabel Tritschler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Tritschler. Isabel Tritschler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Proteomic profiling of human bone from different anatomical sites – A pilot study 2022 ·PROTEOMICS - CLINICAL APPLICATIONS ·Tobias Fretwurst, Isabel Tritschler, René Rothweiler, Susanne Nahles, Brigitte Altmann, Oliver Schilling, Katja Nelson	11
2	Transforming growth factor-β pathway activity in glioblastoma 2015 ·Oncotarget ·Karl Frei, Dorothee Gramatzki, Isabel Tritschler, (unknown), (unknown), Elisabeth J. Rushing, Michael Weller	83
3	Differential regulation of TGF-β–induced, ALK-5–mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma 2014 ·Neuro-Oncology ·Katharina Seystahl, Isabel Tritschler, Emese Szabó, Ghazaleh Tabatabai, Michael Weller	63
4	Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy 2014 ·Genes & Development ·Kenneth Yan, Qiulian Wu, (unknown), Christine Lee, (unknown), Isabel Tritschler, Jennifer DeVecchio, Matthew F. Kalady, Anita B. Hjelmeland, Jeremy N. Rich	115
5	The management of lomustine overdose in malignant glioma patients 2014 ·Neuro-Oncology Practice ·Hans‐Georg Wirsching, Isabel Tritschler, Antonella Palla, Christoph Renner, Michael Weller, Ghazaleh Tabatabai	9
6	Integrin control of the transforming growth factor-β pathway in glioblastoma 2013 ·Brain ·Patrick Roth, Manuela Silginer, Simon L. Goodman, Kathy Hasenbach, Svenja Thies, Gerald Maurer, Peter Schraml, Ghazaleh Tabatabai, Holger Moch, Isabel Tritschler, Michael Weller	91
7	A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells 2013 ·Neuro-Oncology ·Fabian Wolpert, Isabel Tritschler, Alexander Steinle, Michael Weller, Günter Eisele	49
8	Effect of the integrin inhibitor cilengitide on TGF-beta signaling. 2012 ·Journal of Clinical Oncology ·Michael Weller, Manuela Silginer, Simon L. Goodman, Kathy Hasenbach, Svenja Thies, Peter Schraml, Ghazaleh Tabatabai, Holger Moch, Isabel Tritschler, (unknown)	5
9	An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor breakdown → 2011 ·Nature ·Christiane A. Opitz, Ulrike Litzenburger, Felix Sahm, Martina Ott, Isabel Tritschler, Saskia Trump, Theresa Schumacher, Leonie Jestaedt, Dieter Schrenk, Michael Weller, Manfred Jugold, Gilles J. Guillemin, Christine L. Miller, Christian Lutz, Bernhard Radlwimmer, Irina Lehmann, Andreas von Deimling, Wolfgang Wick, Michael Platten	1443
10	GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas 2010 ·Clinical Cancer Research ·Patrick Roth, Markus Junker, Isabel Tritschler, Michel Mittelbronn, Yvonne Dombrowski, Samuel N. Breit, Ghazaleh Tabatabai, Wolfgang Wick, Michael Weller, Jörg Wischhusen	139
11	Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells 2009 ·Oncogene ·Dorothee Gramatzki, (unknown), Jens Schittenhelm, Ghazaleh Tabatabai, Christoph Köhle, Wolfgang Wick, Markus Schwarz, Michael Weller, Isabel Tritschler	108
12	Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer 2009 ·International Journal of Cancer ·Derek Zieker, Ingmar Königsrainer, Isabel Tritschler, Markus Löffler, Stefan Beckert, Frank Traub, Kay Nieselt, Sarah Bühler, Michael Weller, Jochen Gaedcke, Russell S. Taichman, Hinnak Northoff, Björn L.D.M. Brücher, Alfred Königsrainer	110
13	Modulation of TGF‐β activity by latent TGF‐β‐binding protein 1 in human malignant glioma cells 2009 ·International Journal of Cancer ·Isabel Tritschler, Dorothee Gramatzki, David Capper, Michel Mittelbronn, Richard Meyermann, Juha Saharinen, Wolfgang Wick, Jorma Keski‐Oja, Michael Weller	49
14	Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-β and Protein Kinase R 2009 ·Stem Cells ·Christiane A. Opitz, Ulrike Litzenburger, Christian Lutz, Tobias V. Lanz, Isabel Tritschler, (unknown), Eva Tolosa, M. Hoberg, Jan Anderl, Wilhelm K. Aicher, Michael Weller, Wolfgang Wick, Michael Platten	260
15	Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro 2009 ·Neuro-Oncology ·Gabriele D. Maurer, Isabel Tritschler, Barbara J. Adams, Ghazaleh Tabatabai, Wolfgang Wick, Roger Stupp, Michael Weller	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact